期刊
CLINICS IN DERMATOLOGY
卷 30, 期 6, 页码 657-661出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.clindermatol.2011.09.018
关键词
-
类别
After a long period of relative inactivity in the introduction of new antifungals, more recently a few new drugs of already existing classes have been introduced. These represent small or large advantages and differences compared with existing available alternative therapy for deep and systemic mycoses. The 3 newest drugs include posaconazole, micafungin, and anidulafungin, whose pharmacology, toxicology, and indications are presented. (C) 2012 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据